Wuensche, Thomas E.
Stergiou, Natascha
Mes, Iris
Verlaan, Mariska
Kooijman, Esther J. M.
Windhorst, Albert D.
Jensen, Allan
Asuni, Ayodeji A.
Bang-Andersen, Benny
van Dongen, Guus A. M. S.
Vugts, Danielle J.
Beaino, Wissam
Funding for this research was provided by:
European Union's Horizon 2020 research and innovation program (Marie Skłodowska-Curie grant agreement No 813528)
Article History
Received: 16 January 2024
Revised: 27 May 2024
Accepted: 19 June 2024
First Online: 2 August 2024
Declarations
:
: Allan Jensen, Ayodeji A. Asuni and Benny Bang-Andersen are paid employees of Lundbeck. Guus A.M.S van Dongen has the paid (part-time) position of chief scientific officer at LinXis Biopharmaceuticals. No other potential conflict of interest relevant to this article was reported.